NYSE:NXN

Nuveen New York Select Tax-Free Income Portfolio - NXN Stock Forecast, Price & News

$12.17

+0.05 (+0.41%)

(As of 08/11/2022 12:00 AM ET)

Add

Compare

Today's Range: $12.08
▼
$12.24
50-Day Range: $11.38
▼
$12.17
52-Week Range: $11.30
▼
$14.50

Volume: 4,579 shs
Average Volume: 8,536 shs
Market Capitalization: $47.77 million

P/E Ratio: N/A
Dividend Yield: 3.38%
Price Target: N/A

About Nuveen New York Select Tax-Free Income Portfolio

Nuveen New York Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in the securities of companies that operate across diversified sectors. It primarily invests in municipal bonds with an average credit quality of Baa/BBB or better. The fund employs fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against Barclays Capital New York Municipal Bond Index and S&P New York Municipal Bond Index. Nuveen New York Select Tax-Free Income Portfolio was formed on June 19, 1992 and is domiciled in the United States.

Nuveen New York Select Tax-Free Income Portfolio Trading Up 0.4 %

NXN opened at $12.17 on Friday. Nuveen New York Select Tax-Free Income Portfolio has a twelve month low of $11.30 and a twelve month high of $14.50. The company has a fifty day moving average of $11.82 and a 200-day moving average of $12.27.

Nuveen New York Select Tax-Free Income Portfolio Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Thursday, September 1st. Stockholders of record on Monday, August 15th will be given a dividend of $0.033 per share. This represents a $0.40 annualized dividend and a dividend yield of 3.25%. The ex-dividend date is Friday, August 12th.

Receive NXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen New York Select Tax-Free Income Portfolio and its competitors with MarketBeat's FREE daily newsletter.

NXN Stock News Headlines

August 5, 2022 | bizjournals.com

Largest New York state tax incentives

May 6, 2022 | seekingalpha.com

Nuveen New York Select Tax-Free Income Portfolio declares $0.033 dividend

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen New York Select Tax-Free Income Portfolio and its competitors with MarketBeat's FREE daily newsletter.

NXN Company Calendar

Ex-Dividend for 8/1 Dividend: 7/14/2022
Dividend Payable: 8/01/2022
Today: 8/12/2022
Ex-Dividend for 9/1 Dividend: 8/12/2022
Dividend Payable: 9/01/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Investment offices, not elsewhere classified
Sub-Industry: N/A
Sector: Finance
Current Symbol: NYSE:NXN
CUSIP: N/A
CIK: 885731
Web: www.nuveen.com
Phone: 13129178200
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 3,925,000
Free Float: N/A
Market Cap: $47.77 million
Optionable: Not Optionable
Beta: 0.22

Key Executives

Dr. Scott R. Romans
Portfolio Mang.
Dr. Cathryn P. Steeves
Portfolio Mang.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NXN Stock - Frequently Asked Questions

How have NXN shares performed in 2022?: Nuveen New York Select Tax-Free Income Portfolio's stock was trading at $13.61 on January 1st, 2022. Since then, NXN stock has decreased by 10.6% and is now trading at $12.17.
View the best growth stocks for 2022 here.
Are investors shorting Nuveen New York Select Tax-Free Income Portfolio?: Nuveen New York Select Tax-Free Income Portfolio saw a decline in short interest in July. As of July 31st, there was short interest totaling 1,600 shares, a decline of 59.0% from the July 15th total of 3,900 shares. Based on an average daily trading volume, of 10,600 shares, the short-interest ratio is currently 0.2 days.
View Nuveen New York Select Tax-Free Income Portfolio's Short Interest.
How often does Nuveen New York Select Tax-Free Income Portfolio pay dividends? What is the dividend yield for Nuveen New York Select Tax-Free Income Portfolio?: Nuveen New York Select Tax-Free Income Portfolio declared a monthly dividend on Wednesday, August 3rd. Stockholders of record on Monday, August 15th will be paid a dividend of $0.033 per share on Thursday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 3.25%. The ex-dividend date is Friday, August 12th.
Read our dividend analysis for NXN.
Is Nuveen New York Select Tax-Free Income Portfolio a good dividend stock?: Nuveen New York Select Tax-Free Income Portfolio (NYSE:NXN) pays an annual dividend of $0.41 per share and currently has a dividend yield of 3.38%.
Read our dividend analysis for NXN.

What other stocks do shareholders of Nuveen New York Select Tax-Free Income Portfolio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen New York Select Tax-Free Income Portfolio investors own include KeyCorp (KEY), Canadian Natural Resources (CNQ), Consolidated Edison (ED), Gilead Sciences (GILD), PacWest Bancorp (PACW), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Algonquin Power & Utilities (AQN) and BCE (BCE).
What is Nuveen New York Select Tax-Free Income Portfolio's stock symbol?: Nuveen New York Select Tax-Free Income Portfolio trades on the New York Stock Exchange (NYSE) under the ticker symbol "NXN."
Who are Nuveen New York Select Tax-Free Income Portfolio's major shareholders?: Nuveen New York Select Tax-Free Income Portfolio's stock is owned by a variety of institutional and retail investors. Top institutional investors include Tortoise Investment Management LLC (4.40%), Commonwealth Equity Services LLC (0.34%) and UBS Group AG (0.31%).
View institutional ownership trends.
How do I buy shares of Nuveen New York Select Tax-Free Income Portfolio?: Shares of NXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Nuveen New York Select Tax-Free Income Portfolio's stock price today?: One share of NXN stock can currently be purchased for approximately $12.17.
How much money does Nuveen New York Select Tax-Free Income Portfolio make?: Nuveen New York Select Tax-Free Income Portfolio (NYSE:NXN) has a market capitalization of $47.77 million.
How can I contact Nuveen New York Select Tax-Free Income Portfolio?: The official website for the company is www.nuveen.com. The company can be reached via phone at 13129178200.

This page (NYSE:NXN) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources